Doxycycline Hyclate NDC 62332-352

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-352Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0352Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-352-31	62332035231	100 TABLET, FILM COATED in 1 BOTTLE (62332-352-31)Marketed from Mar 5, 2020
62332-352-60	62332035260	60 TABLET, FILM COATED in 1 BOTTLE (62332-352-60)Marketed from Mar 5, 2020
62332-352-91	62332035291	1000 TABLET, FILM COATED in 1 BOTTLE (62332-352-91)Marketed from Mar 5, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxycycline Hyclate
Generic name (nonproprietary): doxycycline hyclate
Active ingredients: Doxycycline hyclate — 20 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210537
Marketing start: Mar 5, 2020
Listing expires: Dec 31, 2026
Other FDA classes: Tetracyclines (Chemical structure)
Identifiers: Product ID 62332-352_9d36c4e4-75df-42af-bd04-37ccfe7664a7SPL ID 9d36c4e4-75df-42af-bd04-37ccfe7664a7SPL set ID 7c33c1b8-100e-4df8-be8d-de3eed7ced94RxCUI 283535UNII 19XTS3T51U
Pharmacologic class: Tetracycline-class Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332035231 followed by a unit qualifier and the quantity

Package 62332-0352-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 30, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Doxycycline hyclate tablets are indicated for use as an adjunct to scaling and root planing to promote attachment level gain and to reduce pocket depth in patients with adult periodontitis.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210537

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210537
Product	Strength	Form · route	Labeler	Product NDC
Doxycycline Hyclate	Doxycycline hyclate 20 mg/1	Tablet, Film coatedOral	Alembic Pharmaceuticals Limited	46708-352